+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Prefilled Syringes Market Size, Share & Industry Trends Analysis Report by Application, Therapeutics, Material, Design, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 98 Pages
  • September 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5673801
The North America Prefilled Syringes Market would witness market growth of 10.1% CAGR during the forecast period (2022-2028).

Standard syringes include closely fitting glass rods as well as cylindrical glass barrels, which are substantially more costly to produce than prefilled cartridges with a plastic base and the associated syringes. Prefilled cartridges are also significantly less likely to crack or break than their regular, glass equivalents. Patients get precise dosing due to prefilled syringe cartridges. In addition, patients who are required to self-inject medication yet lack medical knowledge will particularly benefit from this.

Four essential parts make up prefilled syringes: a plunger, barrel, stopper, and needle. The plunger & stopper need to fit snugly within the barrel for the system to work effectively, yet they must glide over it when pressure is given. Elastomer stoppers' slight sticky surface, which tends to rub across the surface of the barrel, could occasionally cause issues. The break-loose force is the level of force required to overcome the plunger's static friction. If such a force is excessively high, the syringe gets harder and harder to operate, which makes it more challenging to deliver the medication and less comfortable for the patient.

According to reports, there are 0.5 cases of (rheumatoid arthritis) RA per 1000 persons each year in the United States. RA affects 1-2% of people, and the epidemiology varies by region and ethnicity. There have been reports of a higher incidence in some Indigenous populations. Numerous researchers have noted epidemiologic variation in the frequency and prevalence of RA, with a general downward trend in prevalence over time. Although there are Canadian standards for identifying and treating anaphylaxis, there is little data on how pre-hospital and emergency department management actually differs throughout Canada.

The US market dominated the North America Prefilled Syringes Market by Country in 2021; thereby, achieving a market value of $2.6 billion by 2028. The Canada market is estimated to grow at a CAGR of 12.6% during (2022-2028). Additionally, The Mexico market would witness a CAGR of 11.6% during (2022-2028).

Based on Application, the market is segmented into Diabetes, Anaphylaxis, Rheumatoid Arthritis, and Others. Based on Therapeutics, the market is segmented into Large Molecules and Small Molecules. Based on Material, the market is segmented into Glass-based and Plastic-based. Based on Design, the market is segmented into Single-chamber, Dual-chamber, and Customized. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Medtronic PLC, Nipro Corporation, Terumo Corporation, Vetter Pharma, West Pharmaceutical Services, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Others

By Therapeutics

  • Large Molecules
  • Small Molecules

By Material

  • Glass-based
  • Plastic-based

By Design

  • Single-chamber
  • Dual-chamber
  • Customized

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Bayer AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Gerresheimer AG
  • Medtronic PLC
  • Nipro Corporation
  • Terumo Corporation
  • Vetter Pharma
  • West Pharmaceutical Services, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Prefilled Syringes Market, by Application
1.4.2 North America Prefilled Syringes Market, by Therapeutics
1.4.3 North America Prefilled Syringes Market, by Material
1.4.4 North America Prefilled Syringes Market, by Design
1.4.5 North America Prefilled Syringes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Prefilled Syringes Market by Application
4.1 North America Diabetes Market by Country
4.2 North America Anaphylaxis Market by Country
4.3 North America Rheumatoid Arthritis Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Prefilled Syringes Market by Therapeutics
5.1 North America Large Molecules Market by Country
5.2 North America Small Molecules Market by Country
Chapter 6. North America Prefilled Syringes Market by Material
6.1 North America Glass-based Market by Country
6.2 North America Plastic-based Market by Country
Chapter 7. North America Prefilled Syringes Market by Design
7.1 North America Single-chamber Market by Country
7.2 North America Dual-chamber Market by Country
7.3 North America Customized Market by Country
Chapter 8. North America Prefilled Syringes Market by Country
8.1 US Prefilled Syringes Market
8.1.1 US Prefilled Syringes Market by Application
8.1.2 US Prefilled Syringes Market by Therapeutics
8.1.3 US Prefilled Syringes Market by Material
8.1.4 US Prefilled Syringes Market by Design
8.2 Canada Prefilled Syringes Market
8.2.1 Canada Prefilled Syringes Market by Application
8.2.2 Canada Prefilled Syringes Market by Therapeutics
8.2.3 Canada Prefilled Syringes Market by Material
8.2.4 Canada Prefilled Syringes Market by Design
8.3 Mexico Prefilled Syringes Market
8.3.1 Mexico Prefilled Syringes Market by Application
8.3.2 Mexico Prefilled Syringes Market by Therapeutics
8.3.3 Mexico Prefilled Syringes Market by Material
8.3.4 Mexico Prefilled Syringes Market by Design
8.4 Rest of North America Prefilled Syringes Market
8.4.1 Rest of North America Prefilled Syringes Market by Application
8.4.2 Rest of North America Prefilled Syringes Market by Therapeutics
8.4.3 Rest of North America Prefilled Syringes Market by Material
8.4.4 Rest of North America Prefilled Syringes Market by Design
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.4 Gerresheimer AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 West Pharmaceutical Services, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Nipro Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 Terumo Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Regional Analysis
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.5.2 Geographical Expansions:
9.8 Baxter International, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.9 Bayer AG
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Approvals and Trials:
9.10. Vetter Pharma
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Partnerships, Collaborations, and Agreements:
9.10.2.2 Geographical Expansions:

Companies Mentioned

  • Abbott Laboratories
  • Bayer AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Gerresheimer AG
  • Medtronic PLC
  • Nipro Corporation
  • Terumo Corporation
  • Vetter Pharma
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...